383 related articles for article (PubMed ID: 7959299)
1. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro.
Burger RA; Grosen EA; Ioli GR; Van Eden ME; Brightbill HD; Gatanaga M; DiSaia PJ; Granger GA; Gatanaga T
Gynecol Oncol; 1994 Nov; 55(2):294-303. PubMed ID: 7959299
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of interleukin-1 receptor antagonist (IL-1RA) and tumor necrosis factor binding protein (TNF-BP) in a rodent abscess model of host resistance.
Colagiovanni DB; Shopp GM
Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):397-419. PubMed ID: 8872492
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.
Kimble RB; Matayoshi AB; Vannice JL; Kung VT; Williams C; Pacifici R
Endocrinology; 1995 Jul; 136(7):3054-61. PubMed ID: 7789332
[TBL] [Abstract][Full Text] [Related]
4. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
Tsao TC; Hong Jh; Li LF; Hsieh MJ; Liao SK; Chang KS
Chest; 2000 Jan; 117(1):103-9. PubMed ID: 10631206
[TBL] [Abstract][Full Text] [Related]
5. Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB.
Tsao TC; Li L; Hsieh M; Liao S; Chang KS
Eur Respir J; 1999 Sep; 14(3):490-5. PubMed ID: 10543265
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
[TBL] [Abstract][Full Text] [Related]
7. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans.
Bargetzi MJ; Lantz M; Smith CG; Torti FM; Olsson I; Eisenberg SP; Starnes HF
Cancer Res; 1993 Sep; 53(17):4010-3. PubMed ID: 8395334
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis.
Matsuo K; Ikizler TA; Hoover RL; Nakamoto M; Yasunaga C; Pupim LB; Hakim RM
Kidney Int; 2000 Feb; 57(2):697-708. PubMed ID: 10652049
[TBL] [Abstract][Full Text] [Related]
10. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
[TBL] [Abstract][Full Text] [Related]
11. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus.
Tillie-Leblond I; Pugin J; Marquette CH; Lamblin C; Saulnier F; Brichet A; Wallaert B; Tonnel AB; Gosset P
Am J Respir Crit Care Med; 1999 Feb; 159(2):487-94. PubMed ID: 9927362
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1.
Sutton ET; Thomas T; Bryant MW; Landon CS; Newton CA; Rhodin JA
J Submicrosc Cytol Pathol; 1999 Jul; 31(3):313-23. PubMed ID: 10626000
[TBL] [Abstract][Full Text] [Related]
13. Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis.
Rodríguez-Ramos C; Galan F; Díaz F; Elvira J; Martín-Herrera L; Girón-González JA
Dig Dis Sci; 2001 Aug; 46(8):1668-76. PubMed ID: 11508666
[TBL] [Abstract][Full Text] [Related]
14. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
15. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
[TBL] [Abstract][Full Text] [Related]
16. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
[TBL] [Abstract][Full Text] [Related]
18. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis.
Law K; Weiden M; Harkin T; Tchou-Wong K; Chi C; Rom WN
Am J Respir Crit Care Med; 1996 Feb; 153(2):799-804. PubMed ID: 8564135
[TBL] [Abstract][Full Text] [Related]
19. Release of soluble TNF/LT receptors from a human ovarian tumor cell line (PA-1) by stimulation with cytokines in vitro.
Gatanaga M; Grosen EA; Burger RA; Granger GA; Gatanaga T
Lymphokine Cytokine Res; 1993 Aug; 12(4):249-53. PubMed ID: 8218597
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
